Ignite Creation Date:
2024-05-06 @ 8:24 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06360458
Status:
RECRUITING
Last Update Posted:
2024-04-11
First Post:
2024-04-07
Brief Title:
Methylprednisolone Adjunctive to Endovascular Treatment for Stroke
Sponsor:
Wan-Jin Chen
Organization:
First Affiliated Hospital of Fujian Medical University
Study Overview
Official Title:
Methylprednisolone in Adjunctive to Endovascular Treatment for Patients With Acute Ischemic Strokes With Established Large Infarct A Multicenter Randomized Double-blind Placebo-controlled Trial MIRACLE
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The efficacy and safety of methylprednisolone in acute ischemic stroke patients with large infarct cores ASPECTS score 6 due to anterior circulation large vessel occlusion have not been clearly established This is a multi-center randomized double-blind placebo-controlled trial to investigate early combination therapy with methylprednisolone for reperfusion in acute large core infarction
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None